Skip to main content
Terug
Watch Compare

MEDIFAST INC

Datakwaliteit: 100%
MED
NYSE Manufacturing Food Products
€ 10,21
▼ € 0,02 (-0,15%)
Marktkapitalisatie: 112,58 M
Prijs
€ 10,21
Marktkapitalisatie
112,58 M
Dagbereik
€ 10,10 — € 10,26
52-Weeksbereik
€ 9,22 — € 15,46
Volume
175.513
Openen € 10,12
50D / 200D Gem.
€ 10,59
3,62% below
50D / 200D Gem.
€ 12,29
16,96% below

Quick Summary

Belangrijkste Punten

Earnings declined -992,97% over the past year
Generating 1,25 M in free cash flow
Capital efficient — spends only 1,46% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-35,96%
Earnings (1Y)-992,97%
FCF Growth (3Y)-90,59%

Kwaliteit

Return on Equity
-8,67%
Boven sectorgemiddelde (-51,02%)
ROIC-5,05%
Net Margin-4,84%
Op. Margin-3,68%

Veiligheid

Debt / Equity
N/A
Current Ratio4,45
Interest CoverageN/A

Waardering

PE (TTM)
-6,03
Onder sectorgemiddelde (-1,98)
P/B Ratio0,52
EV/EBITDA450,08
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -6,0 -2,0
P/B 0,5 5,1
ROE % -8,7 -51,0
Net Margin % -4,8 -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

ETFs Holding This Stock

AFSM logo AFSM First Trust Active Factor Small Cap ETF
0,34% weight
FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0,27% weight
LQPE logo LQPE PEO AlphaQuest Thematic PE ETF
0,14% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,03% weight
BSVO logo BSVO EA Bridgeway Omni Small-Cap Value ETF
0,03% weight
EES logo EES WisdomTree U.S. SmallCap Fund
0,03% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,02% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0,00% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -35,96% Revenue Growth (3Y) -40,01%
Earnings Growth (1Y) -992,97% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 385,79 M Net Income (TTM) -18,67 M
ROE -8,67% ROA -6,95%
Gross Margin 71,33% Operating Margin -3,68%
Net Margin -4,84% Free Cash Flow (TTM) 1,25 M
ROIC -5,05% FCF Growth (3Y) -90,59%
Safety
Debt / Equity N/A Current Ratio 4,45
Interest Coverage N/A Asset Turnover 1,44
Working Capital 161,13 M Tangible Book Value 214,71 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6,03 Forward P/E N/A
P/B Ratio 0,52 P/S Ratio 0,29
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 450,08 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1,11%
Market Cap 112,58 M Enterprise Value 13,05 M
Per Share
EPS (Diluted TTM) -1,70 Revenue / Share 34,97
FCF / Share 0,11 OCF / Share 0,62
EPS CAGR (1Y) -994,74% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,46% FCF Conversion -6,69%
SBC-Adj. FCF -4,82 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 385,79 M 602,46 M 1,07 B — —
Net Income -18,67 M 2,09 M 99,42 M 143,57 M 164,03 M
EPS (Diluted) -1,70 0,19 9,10 12,73 13,89
Gross Profit 275,19 M 444,62 M 775,85 M 1,14 B 1,13 B
Operating Income -14,21 M 2,88 M 126,40 M 184,81 M 216,24 M
EBITDA — — — — —
R&D Expenses 4,30 M 4,60 M 4,60 M 4,50 M 4,40 M
SG&A Expenses 289,40 M 441,75 M 649,45 M 955,61 M 911,36 M
D&A 14,24 M 12,71 M 13,11 M 10,98 M 6,81 M
Interest Expense — — — — —
Income Tax 13,03 M 1,70 M 29,38 M 40,49 M 52,10 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 247,97 M 284,21 M 309,91 M 316,21 M 398,33 M
Total Liabilities 49,05 M 74,10 M 108,43 M 161,17 M 195,85 M
Shareholders' Equity 198,92 M 210,11 M 201,48 M 155,04 M 202,47 M
Total Debt — — — — —
Cash & Equivalents 89,30 M 90,93 M 94,44 M 87,69 M 104,18 M
Current Assets 201,68 M 214,40 M 224,03 M 222,78 M 306,87 M
Current Liabilities 42,96 M 64,16 M 92,30 M 140,89 M 169,83 M